Tissue Regenix Group announces that Chief Executive Officer Steve Couldwell, has informed the Board that due to a recurrence of his illness, he has decided to resign his position with immediate effect in order to concentrate on his recovery. John Samuel, will resume the position of Executive Chairman until a full time CEO appointment is made. Gareth Jones, Chief Operating Officer will take up the position of interim- CEO.

Mike Barker, who has been with the Group since January will continue to support the Executive team as interim Finance Director.